Jeong M - Search Results

1

Recent Advances in Substrate-Controlled Asymmetric Induction Derived from Chiral Pool α-Amino Acids for Natural Product Synthesis.

Paek SM, Jeong M, Jo J, Heo YM, Han YT, Yun H. Paek SM, et al. Among authors: jeong m. Molecules. 2016 Jul 21;21(7):951. doi: 10.3390/molecules21070951. Molecules. 2016. PMID: 27455209 Free PMC article. Review.

2

Discovery and SAR studies of novel 2-anilinopyrimidine-based selective inhibitors against triple-negative breast cancer cell line MDA-MB-468.

Jo J, Kim SH, Kim H, Jeong M, Kwak JH, Taek Han Y, Jeong JY, Jung YS, Yun H. Jo J, et al. Among authors: jeong m, jeong jy. Bioorg Med Chem Lett. 2019 Jan 1;29(1):62-65. doi: 10.1016/j.bmcl.2018.11.010. Epub 2018 Nov 8. Bioorg Med Chem Lett. 2019. PMID: 30447889

3

Total Synthesis of Anmindenol A and Its Application to the Design, Synthesis, and Biological Evaluation of Derivatives Thereof.

Jo J, Jeong M, Ahn JS, Akter J, Kim HS, Suh YG, Yun H. Jo J, et al. Among authors: jeong m. J Org Chem. 2019 Sep 6;84(17):10953-10961. doi: 10.1021/acs.joc.9b01564. Epub 2019 Aug 12. J Org Chem. 2019. PMID: 31357857

4

RKIP Induction Promotes Tumor Differentiation via SOX2 Degradation in NF2-Deficient Conditions.

Cho JH, Park S, Kim S, Kang SM, Woo TG, Yoon MH, Lee H, Jeong M, Park YH, Kim H, Han YT, Suh YG, Kim BH, Kwon Y, Yun H, Park BJ. Cho JH, et al. Among authors: jeong m. Mol Cancer Res. 2022 Mar 1;20(3):412-424. doi: 10.1158/1541-7786.MCR-21-0373. Mol Cancer Res. 2022. PMID: 34728553

5

Aryl hydrocarbon receptor-targeted therapy for CD4+ T cell-mediated idiopathic pneumonia syndrome in mice.

Lee SM, Kim CE, Park HY, Yoon EH, Won HJ, Ahn JM, Nguyen NZN, Kim M, Jang WH, Lee WS, Kang MS, Jeong M, Yun H, Park S, Wu S, Kim DH, Kwon B, Seo SK. Lee SM, et al. Among authors: jeong m. Blood. 2022 Jun 2;139(22):3325-3339. doi: 10.1182/blood.2021013849. Blood. 2022. PMID: 35226727 Free article.

6

A bioisosteric approach to the discovery of novel N-aryl-N'-[4-(aryloxy)cyclohexyl]squaramide-based activators of eukaryotic initiation factor 2 alpha (eIF2α) phosphorylation.

Kwak J, Kim MJ, Kim S, Park GB, Jo J, Jeong M, Kang S, Moon S, Bang S, An H, Hwang S, Kim MS, Yoo JW, Moon HR, Chang W, Chung KW, Jeong JY, Yun H. Kwak J, et al. Among authors: jeong m, jeong jy. Eur J Med Chem. 2022 Sep 5;239:114501. doi: 10.1016/j.ejmech.2022.114501. Epub 2022 May 29. Eur J Med Chem. 2022. PMID: 35716517

7

AM-18002, a derivative of natural anmindenol A, enhances radiosensitivity in mouse breast cancer cells.

Eum DY, Jeong M, Park SY, Kim J, Jin Y, Jo J, Shim JW, Lee SR, Park SJ, Heo K, Yun H, Choi YJ. Eum DY, et al. Among authors: jeong m. PLoS One. 2024 Apr 16;19(4):e0296989. doi: 10.1371/journal.pone.0296989. eCollection 2024. PLoS One. 2024. PMID: 38625901 Free PMC article.

8

RUFY4 deletion prevents pathological bone loss by blocking endo-lysosomal trafficking of osteoclasts.

Kim M, Park JH, Go M, Lee N, Seo J, Lee H, Kim D, Ha H, Kim T, Jeong MS, Kim S, Kim T, Kim HS, Kang D, Shim H, Lee SY. Kim M, et al. Among authors: jeong ms. Bone Res. 2024 May 15;12(1):29. doi: 10.1038/s41413-024-00326-8. Bone Res. 2024. PMID: 38744829

9

Interprofessional Educational Needs for Shared Governance of Integrated Care.

Park M, Choi E, Jeong M, Seo HJ, Kim J, Seo E. Park M, et al. Among authors: jeong m. Int J Integr Care. 2024 May 6;24(1):15. doi: 10.5334/ijic.7674. eCollection 2024 Apr-Jun. Int J Integr Care. 2024. PMID: 38736721 Free PMC article.

10

Nutritional modulation of antitumor immunity.

Jeong M, Collins N. Jeong M, et al. Curr Opin Immunol. 2024 May 9;87:102422. doi: 10.1016/j.coi.2024.102422. Online ahead of print. Curr Opin Immunol. 2024. PMID: 38728931 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,161 results

Search Page